Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 305

1.

Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence.

Cheng J, Cuk K, Heil J, Golatta M, Schott S, Sohn C, Schneeweiss A, Burwinkel B, Surowy H.

Oncotarget. 2017 Apr 24;8(33):54537-54547. doi: 10.18632/oncotarget.17384. eCollection 2017 Aug 15.

PMID:
28903362
2.

Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study.

Zeidan AM, Long JB, Wang R, Hu X, Yu JB, Huntington SF, Abel GA, Mougalian SS, Podoltsev NA, Gore SD, Gross CP, Ma X, Davidoff AJ.

PLoS One. 2017 Sep 13;12(9):e0184747. doi: 10.1371/journal.pone.0184747. eCollection 2017.

3.

FMECA Application to Intraoperative Electron Beam Radiotherapy Procedure As a Quality Method to Prevent and Reduce Patient's Risk in Conservative Surgery for Breast Cancer.

Vidali C, Severgnini M, Urbani M, Toscano L, Perulli A, Bortul M.

Front Med (Lausanne). 2017 Aug 28;4:138. doi: 10.3389/fmed.2017.00138. eCollection 2017.

4.

Evaluation of Partial Breast Reirradiation with Intraoperative Radiotherapy after Prior Thoracic Radiation: A Single-Institution Report of Outcomes and Toxicity.

Chin C, Jadeja P, Taback B, Horowitz DP, Feldman SM, Ha R, Connolly EP.

Front Oncol. 2017 Aug 28;7:175. doi: 10.3389/fonc.2017.00175. eCollection 2017.

5.
6.

Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells.

Wu PH, Onodera Y, Ichikawa Y, Rankin EB, Giaccia AJ, Watanabe Y, Qian W, Hashimoto T, Shirato H, Nam JM.

Int J Nanomedicine. 2017 Jul 14;12:5069-5085. doi: 10.2147/IJN.S137833. eCollection 2017.

7.

Autologous Fat Grafting as a Novel Antiestrogen Vehicle for the Treatment of Breast Cancer.

Thomas S, Chen S, Sbitany H, Kwon E, Piper M, Park J, Terranova Barberio M, Pawlowska N, Munster PN.

Plast Reconstr Surg. 2017 Sep;140(3):537-544. doi: 10.1097/PRS.0000000000003579.

PMID:
28841614
8.

Cancer Care at Times of Crisis and War: The Syrian Example.

Sahloul E, Salem R, Alrez W, Alkarim T, Sukari A, Maziak W, Atassi MB.

J Glob Oncol. 2016 Aug 31;3(4):338-345. doi: 10.1200/JGO.2016.006189. eCollection 2017 Aug.

9.

Oncological safety and cosmetic outcomes in oncoplastic breast conservation surgery, a review of the best level of evidence literature.

Campbell EJ, Romics L.

Breast Cancer (Dove Med Press). 2017 Aug 4;9:521-530. doi: 10.2147/BCTT.S113742. eCollection 2017. Review.

10.

Early health technology assessment of magnetic resonance-guided high intensity focused ultrasound ablation for the treatment of early-stage breast cancer.

Knuttel FM, Huijsse SEM, Feenstra TL, Moonen CTW, van den Bosch MAAJ, Buskens E, Greuter MJW, de Bock GH.

J Ther Ultrasound. 2017 Aug 1;5:23. doi: 10.1186/s40349-017-0101-3. eCollection 2017.

11.

A feasibility study of the Mini-AFTER telephone intervention for the management of fear of recurrence in breast cancer survivors: a mixed-methods study protocol.

Cruickshank S, Steel E, Fenlon D, Armes J, Scanlon K, Banks E, Humphris G.

Pilot Feasibility Stud. 2017 Jul 20;4:22. doi: 10.1186/s40814-017-0161-8. eCollection 2018.

12.

Oncoplastic breast surgery in the setting of breast-conserving therapy: A systematic review.

Yoon JJ, Green WR, Kim S, Kearney T, Haffty BG, Eladoumikdachi F, Goyal S.

Adv Radiat Oncol. 2016 Sep 21;1(4):205-215. doi: 10.1016/j.adro.2016.09.002. eCollection 2016 Oct-Dec. Review.

13.

MRI Reduces Variation of Contouring for Boost Clinical Target Volume in Breast Cancer Patients Without Surgical Clips in the Tumour Bed.

Al-Hammadi N, Caparrotti P, Divakar S, Riyas M, Chandramouli SH, Hammoud R, Hayes J, Mc Garry M, Paloor SP, Petric P.

Radiol Oncol. 2017 Mar 17;51(2):160-168. doi: 10.1515/raon-2017-0014. eCollection 2017 Jun.

14.

DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas.

Troester MA, Hoadley KA, D'Arcy M, Cherniack AD, Stewart C, Koboldt DC, Robertson AG, Mahurkar S, Shen H, Wilkerson MD, Sandhu R, Johnson NB, Allison KH, Beck AH, Yau C, Bowen J, Sheth M, Hwang ES, Perou CM, Laird PW, Ding L, Benz CC.

NPJ Breast Cancer. 2016 May 4;2:16007. doi: 10.1038/npjbcancer.2016.7. eCollection 2016.

15.

Survival of Node-negative Breast Cancer Patients Treated at the University Medical Centre Maribor in the Period 2000-2009.

Fokter Dovnik N, Arko D, Čas Sikošek N, Takač I.

Zdr Varst. 2017 May 26;56(3):185-192. doi: 10.1515/sjph-2017-0025. eCollection 2017 Sep.

16.

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08).

van Roozendaal LM, Vane MLG, van Dalen T, van der Hage JA, Strobbe LJA, Boersma LJ, Linn SC, Lobbes MBI, Poortmans PMP, Tjan-Heijnen VCG, Van de Vijver KKBT, de Vries J, Westenberg AH, Kessels AGH, de Wilt JHW, Smidt ML.

BMC Cancer. 2017 Jul 1;17(1):459. doi: 10.1186/s12885-017-3443-x.

17.

A Bayesian network and heuristic approach for systematic characterization of radiotherapy receipt after breast-conservation surgery.

Soto-Ferrari M, Prieto D, Munene G.

BMC Med Inform Decis Mak. 2017 Jun 28;17(1):93. doi: 10.1186/s12911-017-0479-4.

18.

Seroma change during magnetic resonance imaging-guided partial breast irradiation and its clinical implications.

Jeon SH, Shin KH, Park SY, Kim JI, Park JM, Kim JH, Chie EK, Wu HG.

Radiat Oncol. 2017 Jun 20;12(1):103. doi: 10.1186/s13014-017-0843-7.

19.

Single nucleotide polymorphisms and unacceptable late toxicity in breast cancer adjuvant radiotherapy: a case report.

Lazzari G, Natalicchio MI, Terlizzi A, Perri F, Silvano G.

Breast Cancer (Dove Med Press). 2017 May 29;9:401-406. doi: 10.2147/BCTT.S136048. eCollection 2017.

20.

Therapeutic results of a novel enzyme-targeting radiosensitization treatment, Kochi oxydol-radiation therapy for unresectable carcinomas II, in patients with stage I primary breast cancer.

Aoyama N, Ogawa Y, Yasuoka M, Ohgi K, Iwasa H, Miyatake K, Yoshimatsu R, Yamanishi T, Hamada N, Tamura T, Kobayashi K, Murata Y, Miyamura M, Yamagami T.

Oncol Lett. 2017 Jun;13(6):4741-4747. doi: 10.3892/ol.2017.6074. Epub 2017 Apr 21.

Supplemental Content

Support Center